Merck KGaA raises full-year forecast; Perlmutter’s new gig tackles ‘undruggable targets’
The Pharma Data
MAY 5, 2021
Day One pivots to an IPO for more funding to back its work in pediatric cancer ( Endpoints ). AbbVie’s Humira regains top pharma TV spender spot, while sibling brands Rinvoq and Skyrizi tag along ( Fierce ). . FDA approves 100th monoclonal antibody product ( Nature Reviews Drug Discovery ).
52 
Let's personalize your content